CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities:
Net Income (Loss)	$ (4,377,689)	$ (1,540,272)
Adjustments to reconcile net loss to net cash used in by operating activities -
Depreciation and amortization	159,844	156,586
Stock-based compensation expense	1,020,534	749,391
Non-cash interest expense	8,918	13,128
Changes in operating assets and liabilities -
Accounts receivable, net	120,438	(316,362)
Inventories, net	(803,301)	(256,005)
Prepaid expenses	(27,160)	40,176
Accounts payable	476,259	(737,086)
Contract liabilities	493,201	290,235
Accrued compensation and other	(49,209)	(106,789)
Net cash used in operating activities	(2,978,165)	(1,706,998)
Cash Flows from Investing Activities:
Purchases of fixed assets	(180,985)	(260,804)
Reclassification/additional patent costs	31,148	(21,274)
Net cash used in investing activities	(149,837)	(282,078)
Cash Flows from Financing Activities:
Payments of capital lease obligations	(32,257)	(32,164)
Payments of long-term debt	(149,230)	(384,945)
Payments of debt issuance costs	(15,000)	0
Payments/Borrowings on line of credit	(1,000,000)	400,000
Gross proceeds from registered direct offerings of common stock	6,270,136	0
Stock issued for services	151,698	0
Gross proceeds from the exercise of stock options	45,250	5,400
Net cash provided by (used in) financing activities	5,270,597	(11,709)
Net increase (decrease) in cash and cash equivalents	2,142,595	(2,000,785)
Cash and cash equivalents, beginning of period	405,278	2,925,852
Cash and cash equivalents, end of period	$ 2,547,873	$ 925,067